Table of Contents
Journal of Allergy
Volume 2014 (2014), Article ID 983635, 7 pages
http://dx.doi.org/10.1155/2014/983635
Review Article

Probiotics in the Treatment of Chronic Rhinoconjunctivitis and Chronic Rhinosinusitis

Allergy Therapeutics plc., Dominion Way, Worthing, West Sussex BN14 8SA, UK

Received 19 February 2014; Accepted 24 March 2014; Published 28 April 2014

Academic Editor: Ralph Mösges

Copyright © 2014 Matthias F. Kramer and Matthew D. Heath. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Bousquet, N. Khaltaev, A. A. Cruz et al., “Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA2LEN and AllerGen),” Allergy: European Journal of Allergy and Clinical Immunology, vol. 63, no. supplement 86, pp. 8–160, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. D. Jarvis, R. Newson, J. Lotvall et al., “Asthma in adults and its association with chronic rhinosinusitis: the GA2LEN survey in Europe,” Allergy: European Journal of Allergy and Clinical Immunology, vol. 67, no. 1, pp. 91–98, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Rondón, P. Campo, A. Togias et al., “Local allergic rhinitis: concept, pathophysiology, and management,” Journal of Allergy and Clinical Immunology, vol. 129, no. 6, pp. 1460–1467, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. D. G. Powe and N. S. Jones, “Local mucosal immunoglobulin E production: does allergy exist in non-allergic rhinitis?” Clinical and Experimental Allergy, vol. 36, no. 11, pp. 1367–1372, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. D. G. Powe, R. S. Huskisson, A. S. Carney, D. Jenkins, and N. S. Jones, “Evidence for an inflammatory pathophysiology in idiopathic rhinitis,” Clinical and Experimental Allergy, vol. 31, no. 6, pp. 864–872, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. W. J. Fokkens, V. J. Lund, J. Mullol et al., “European position paper on rhinosinusitis and nasal polyps 2012,” Rhinolology Supplements, vol. 3, no. 23, pp. 1–298.
  7. M. F. Kramer and G. Rasp, “Nasal polyposis: eosinophils and interleukin-5,” Allergy: European Journal of Allergy and Clinical Immunology, vol. 54, no. 7, pp. 669–680, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. M. F. Kramer, G. Burow, E. Pfrogner, and G. Rasp, “In vitro diagnosis of chronic nasal inflammation,” Clinical and Experimental Allergy, vol. 34, no. 7, pp. 1086–1092, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. D. W. Thomas and F. R. Greer, “American Academy of pediatrics committee on nutrition; American Academy of pediatrics section on gastroenterology, hepatology, and nutrition. Probiotics and prebiotics in pediatrics,” Pediatrics, vol. 126, no. 6, pp. 1217–1231, 2010. View at Google Scholar
  10. M. C. Berin, “Bugs versus bugs: probiotics, microbiome and allergy,” International Archives of Allergy and Immunology, vol. 163, no. 3, pp. 165–167, 2014. View at Google Scholar
  11. G. Srinivas, S. Moller, J. Wang et al., “Genome-wide mapping of gene-microbiota interactions in susceptibility to autoimmune skin blistering,” Nature Communications, vol. 4, article 2462, 2013. View at Google Scholar
  12. S. Grenham, G. Clarke, J. F. Cryan, and T. G. Dinan, “Brain-gut-microbe communication in health and disease,” Frontiers in Physiology, vol. 2, article 94, 2011. View at Google Scholar
  13. V. Robles Alonso and F. Guarner, “Linking the gut microbiota to human health,” British Journal of Nutrition, supplement 2, pp. S21–S26, 2013. View at Google Scholar
  14. P. J. Turnbaugh, R. E. Ley, M. Hamady, C. M. Fraser-Liggett, R. Knight, and J. I. Gordon, “The human microbiome project,” Nature, vol. 449, no. 7164, pp. 804–810, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. E. K. Costello, C. L. Lauber, M. Hamady, N. Fierer, J. I. Gordon, and R. Knight, “Bacterial community variation in human body habitats across space and time,” Science, vol. 326, no. 5960, pp. 1694–1697, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. E. K. Costello, K. Stagaman, L. Dethlefsen, B. J. M. Bohannan, and D. A. Relmman, “The application of ecological theory toward an understanding of the human microbiome,” Science, vol. 366, p. 1255, 2012. View at Google Scholar
  17. M. Kuitunen, K. Kukkonen, K. Juntunen-Backman et al., “Probiotics prevent IgE-associated allergy until age 5 years in cesarean-delivered children but not in the total cohort,” Journal of Allergy and Clinical Immunology, vol. 123, no. 2, pp. 335–341, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Roduit, S. Scholtens, J. C. de Jongste et al., “Asthma at 8 years of age in children born by caesarean section,” Thorax, vol. 64, no. 2, pp. 107–113, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Jalanka-Tuovinen, A. Salonen, J. Nikkilä et al., “Intestinal microbiota in healthy adults: temporal analysis reveals individual and common core and relation to intestinal symptoms,” PLoS ONE, vol. 6, no. 7, Article ID e23035, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. G. D. Wu, J. Chen, C. Hoffmann et al., “Linking long-term dietary patterns with gut microbial enterotypes,” Science, vol. 334, no. 6052, pp. 105–108, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. P. van Baarlen, F. J. Troost, S. van Hemert et al., “Differential NF-κB pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 7, pp. 2371–2376, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. P. van Baarlen, F. Troost, C. van der Meer et al., “Human mucosal in vivo transcriptome responses to three lactobacilli indicate how probiotics may modulate human cellular pathways,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 1, pp. 4562–4569, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. L. E. M. Niers, H. M. Timmerman, G. T. Rijkers et al., “Identification of strong interleukin-10 inducing lactic acid bacteria which down-regulate T helper type 2 cytokines,” Clinical and Experimental Allergy, vol. 35, no. 11, pp. 1481–1489, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. S. de Roock, M. van Elk, M. E. A. van Dijk et al., “Lactic acid bacteria differ in their ability to induce functional regulatory T cells in humans,” Clinical and Experimental Allergy, vol. 40, no. 1, pp. 103–110, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. N. B. M. M. Rutten, I. B. Van der Vaart, M. Klein, S. De Roock, A. M. Vlieger, and G. T. Rijkers, “In vitro assessment of the immunomodulatory effects of multispecies probiotic formulations for management of allergic diseases,” Beneficial Microbes, vol. 2, no. 3, pp. 183–192, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Snel, Y. M. Vissers, B. A. Smit et al., “Strain-specific immunomodulatory effects of Lactobacillus plantarum strains on birch-pollen-allergic subjects out of season,” Clinical and Experimental Allergy, vol. 41, no. 2, pp. 232–242, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. F. Campeotto, A. Suau, N. Kapel et al., “A fermented formula in pre-term infants: clinical tolerance, gut microbiota, down-regulation of faecal calprotectin and up-regulation of faecal secretory IgA,” British Journal of Nutrition, vol. 105, no. 12, pp. 1843–1851, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. I. Schabussova and U. Wiedermann, “Lactic acid bacteria as novel adjuvant systems for prevention and treatment of atopic diseases,” Current Opinion in Allergy and Clinical Immunology, vol. 8, no. 6, pp. 557–564, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. H. R. Christensen, H. Frøkiær, and J. J. Pestka, “Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells,” Journal of Immunology, vol. 168, no. 1, pp. 171–178, 2002. View at Google Scholar · View at Scopus
  30. J. A. Bravo, M. Julio-Pieper, P. Forsythe et al., “Communication between gastrointestinal bacteria and the nervous system,” Current Opinion in Pharmacology, vol. 12, no. 6, pp. 667–672, 2012. View at Google Scholar
  31. M. G. Gareau, P. M. Sherman, and W. A. Walker, “Probiotics and the gut microbiota in intestinal health and disease,” Nature Reviews. Gastroenterology & Hepatology, vol. 7, no. 9, pp. 503–514, 2010. View at Google Scholar · View at Scopus
  32. Y. Perrin, S. Nutten, R. Audran et al., “Comparison of two oral probiotic preparations in a randomized crossover trial highlights a potentially beneficial effect of Lactobacillus paracasei NCC2461 in patients with allergic rhinitis,” Clinical and Translational Allergy, vol. 4, no. 1, article 1, 2014. View at Publisher · View at Google Scholar
  33. D. P. Strachan, “Hay fever, hygiene, and household size,” British Medical Journal, vol. 299, no. 6710, pp. 1259–1260, 1989. View at Google Scholar · View at Scopus
  34. D. A. Kesper, E. Kilic-Niebergall, and P. I. Pfefferle, “Allergien und Umwelt,” Allergo Journal, vol. 22, no. 7, pp. 464–468, 2013. View at Google Scholar
  35. K. Thestrup-Pedersen, “Atopic eczema. What has caused the epidemic in industrialised countries and can early intervention modify the natural history of atopic eczema?” Journal of Cosmetic Dermatology, vol. 2, no. 3-4, pp. 202–210, 2003. View at Google Scholar
  36. M. Noval Rivas, O. T. Burton, P. Wise et al., “A microbiota signature associated with experimental food allergy promotes allergic sensitization and anaphylaxis,” Journal of Allergy and Clinical Immunology, vol. 131, no. 1, pp. 201–212, 2013. View at Google Scholar
  37. B. Björkstén, P. Naaber, E. Sepp, and M. Mikelsaar, “The intestinal microflora in allergic Estonian and Swedish 2-year-old children,” Clinical and Experimental Allergy, vol. 29, no. 3, pp. 342–346, 1999. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Kalliomäki, P. Kirjavainen, E. Eerola, P. Kero, S. Salminen, and E. Isolauri, “Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing,” Journal of Allergy and Clinical Immunology, vol. 107, no. 1, pp. 129–134, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. J. Penders, K. Gerhold, E. E. Stobberingh et al., “Establishment of the intestinal microbiota and its role for atopic dermatitis in early childhood,” Journal of Allergy and Clinical Immunology, vol. 132, no. 3, pp. 601–607, 2013. View at Google Scholar
  40. M. Kalliomäki, S. Salminen, H. Arvilommi, P. Kero, P. Koskinen, and E. Isolauri, “Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial,” The Lancet, vol. 357, no. 9262, pp. 1076–1079, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Kalliomäki, S. Salminen, T. Poussa, H. Arvilommi, and E. Isolauri, “Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial,” The Lancet, vol. 361, no. 9372, pp. 1869–1871, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. K. Kukkonen, E. Savilahti, T. Haahtela et al., “Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial,” Journal of Allergy and Clinical Immunology, vol. 119, no. 1, pp. 192–198, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. M. V. Kopp, I. Hennemuth, A. Heinzmann, and R. Urbanek, “Randomized, double-blind, placebo-controlled trial of probiotics for primary prevention: no clinical effects of lactobacillus gg supplementation,” Pediatrics, vol. 121, no. 4, pp. e850–e856, 2008. View at Publisher · View at Google Scholar · View at Scopus
  44. P. I. Pfefferle, S. L. Prescott, and M. Kopp, “Microbial influence on tolerance and opportunities for intervention with prebiotics/probiotics and bacterial lysates,” Journal of Allergy and Clinical Immunology, vol. 131, no. 6, pp. 1453–1463, 2013. View at Google Scholar
  45. M. Kuitunen, “Probiotics and prebiotics in preventing food allergy and eczema,” Current Opinion in Allergy and Clinical Immunology, vol. 13, no. 3, pp. 280–286, 2013. View at Google Scholar
  46. R. J. Bertelsen, A. L. Brantsæter, M. C. Magnus et al., “Probiotic milk consumption in pregnancy and infancy and subsequent childhood allergic diseases,” Journal of Allergy and Clinical Immunology, vol. 133, no. 1, pp. 165–171, 2014. View at Google Scholar
  47. T. R. Klaenhammer, M. Kleerebezem, M. V. Kopp, and M. Rescigno, “The impact of probiotics and prebiotics on the immune system,” Nature Reviews Immunology, vol. 12, pp. 728–734, 2012. View at Google Scholar
  48. J. Wassenberg, S. Nutten, R. Audran et al., “Effect of Lactobacillus paracasei ST11 on a nasal provocation test with grass pollen in allergic rhinitis,” Clinical and Experimental Allergy, vol. 41, no. 4, pp. 565–573, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. A. C. Ouwehand, M. Nermes, M. C. Collado, N. Rautonen, S. Salminen, and E. Isolauri, “Specific probiotics alleviate allergic rhinitis during the birch pollen season,” World Journal of Gastroenterology, vol. 15, no. 26, pp. 3261–3268, 2009. View at Publisher · View at Google Scholar · View at Scopus
  50. J. Z. Xiao, S. Kondo, N. Yanagisawa et al., “Effect of probiotic Bifidobacterium longum BBS36 in relieving clinical symptoms and modulating plasma cytokine levels of japanese cedar pollinosis during the pollen season. A randomized double-blind, placebo-controlled trial,” Journal of Investigational Allergology and Clinical Immunology, vol. 16, no. 2, pp. 86–93, 2006. View at Google Scholar · View at Scopus
  51. J.-Z. Xiao, S. Kondo, N. Yanagisawa et al., “Clinical efficacy of probiotic Bifidobacterium longum for the treatment of symptoms of Japanese cedar pollen allergy in subjects evaluated in an environmental exposure unit,” Allergology International, vol. 56, no. 1, pp. 67–75, 2007. View at Publisher · View at Google Scholar · View at Scopus
  52. A. Singh, F. Hacini-Rachinel, M. L. Gosoniu et al., “Immune-modulatory effect of probiotic Bifidobacterium lactis NCC2818 in individuals suffering from seasonal allergic rhinitis to grass pollen: an exploratory, randomized, placebo-controlled clinical trial,” European Journal of Clinical Nutrition, vol. 67, no. 2, pp. 161–167, 2013. View at Google Scholar
  53. M. F. Wang, H. C. Lin, Y. Y. Wang, and C. H. Hsu, “Treatment of perennial allergic rhinitis with lactic acid bacteria,” Pediatric Allergy and Immunology, vol. 15, no. 2, pp. 152–158, 2004. View at Publisher · View at Google Scholar · View at Scopus
  54. Y. Ishida, F. Nakamura, H. Kanzato et al., “Clinical effects of Lactobacillus acidophilus strain L-92 on perennial allergic rhinitis: a double-blind, placebo-controlled study,” Journal of Dairy Science, vol. 88, no. 2, pp. 527–533, 2005. View at Google Scholar · View at Scopus
  55. T. Y. Lin, C. J. Chen, L. K. Chen, S. H. Wen, and R. H. Jan, “Effect of probiotics on allergic rhinitis in Df, Dp or dust-sensitive children: a randomized double blind controlled trial,” Indian Pediatrics, vol. 50, no. 2, pp. 209–213, 2013. View at Google Scholar
  56. W. Y. Lin, L. S. Fu, H. K. Lin, C. Y. Shen, and Y. J. Chen, “Evaluation of the Effect of Lactobacillus paracasei (HF.A00232) in Children (6–13 years old) with Perennial Allergic Rhinitis: a 12-week, Double-blind, Randomized, Placebo-controlled Study,” Pediatrics & Neonatology, 2013. View at Publisher · View at Google Scholar
  57. L. van Overtvelt, V. Lombardi, A. Razafindratsita et al., “IL-10-inducing adjuvants enhance sublingual immunotherapy efficacy in a murine asthma model,” International Archives of Allergy and Immunology, vol. 145, no. 2, pp. 152–162, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. A. Kruisselbrink, M.-J. Heijne Den Bak-Glashouwer, C. E. G. Havenith, J. E. R. Thole, and R. Janssen, “Recombinant Lactobacillus plantarum inhibits house dust mite-specific T-cell responses,” Clinical and Experimental Immunology, vol. 126, no. 1, pp. 2–8, 2001. View at Publisher · View at Google Scholar · View at Scopus
  59. C. Daniel, A. Repa, C. Wild et al., “Modulation of allergic immune responses by mucosal application of recombinant lactic acid bacteria producing the major birch pollen allergen Bet v 1,” Allergy: European Journal of Allergy and Clinical Immunology, vol. 61, no. 7, pp. 812–819, 2006. View at Publisher · View at Google Scholar · View at Scopus
  60. P. Rigaux, C. Daniel, M. Hisbergues et al., “Immunomodulatory properties of Lactobacillus plantarum and its use as a recombinant vaccine against mite allergy,” Allergy: European Journal of Allergy and Clinical Immunology, vol. 64, no. 3, pp. 406–414, 2009. View at Publisher · View at Google Scholar · View at Scopus
  61. M. Schwarzer, A. Repa, C. Daniel et al., “Neonatal colonization of mice with Lactobacillus plantarum producing the aeroallergen Bet v 1 biases towards Th1 and T-regulatory responses upon systemic sensitization,” Allergy: European Journal of Allergy and Clinical Immunology, vol. 66, no. 3, pp. 368–375, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. K. Khazaie, M. Zadeh, M. W. Khan et al., “Abating colon cancer polyposis by Lactobacillus acidophilus deficient in lipoteichoic acid,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, pp. 10462–10467, 2012. View at Google Scholar
  63. S. S. Mukerji, M. A. Pynnonen, H. M. Kim, A. Singer, M. Tabor, and J. E. Terrell, “Probiotics as adjunctive treatment for chronic rhinosinusitis: a randomized controlled trial,” Otolaryngology—Head and Neck Surgery, vol. 140, no. 2, pp. 202–208, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. E. J. Cleland, A. Drilling, A. Bassiouni, C. James, S. Vreugde, and P. J. Wormald, “Probiotic manipulation of the chronic rhinosinusitis microbiome,” International Forum of Allergy & Rhinology, 2014. View at Publisher · View at Google Scholar
  65. A. Smith, F. J. Buchinsky, and J. C. Post, “Eradicating chronic ear, nose, and throat infections: a systematically conducted literature review of advances in biofilm treatment,” Otolaryngology—Head and Neck Surgery, vol. 144, no. 3, pp. 338–347, 2011. View at Publisher · View at Google Scholar · View at Scopus
  66. Q. Hao, Z. Lu, B. R. Dong, C. Q. Huang, and T. Wu, “Probiotics for preventing acute upper respiratory tract infections,” Cochrane Database of Systematic Reviews, vol. 9, Article ID CD006895, 2011. View at Google Scholar · View at Scopus
  67. N. P. West, P. L. Horn, D. B. Pyne et al., “Probiotic supplementation for respiratory and gastrointestinal illness symptoms in healthy physically active individuals,” Clinical Nutrition, 2013. View at Publisher · View at Google Scholar